Learn how subcutaneous nivolumab shifts immunotherapy from IV infusions to quick thigh or abdominal injections, approved in late 2024.

Discover how modern immunotherapy awakens T cells to shrink melanoma tumors, tracked by PET scans and used after surgery to prevent relapse. In this segment, Dr. Morrison provides clinical context ...

Objective and design: The use of proton pump inhibitors in acid-related diseases such as peptic ulcer or erosive reflux oesophagitis is well established. The aim of the current nationwide, multicentre ...

(RTTNews) - Theratechnologies Inc. (THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, has received FDA approval for the intravenous push mode ...

CHICAGO — Administering the bispecific antibody amivantamab (Rybrevant) subcutaneously rather than intravenously in combination with lazertinib (Leclaza) not only reduces administration times but also ...

In the new subcutaneous drug delivery landscape, the growing trend towards patient-friendly, at-home administration is ...

Hurricane season continues to strain the national supply of intravenous fluids to hospitals and dialysis centers around the country. Flooding from Hurricane Helene in late September shut down one of ...

IV fluid maker Baxter said that its plant in North Cove, North Carolina, was impacted by the rain from Helene. The Biden administration has enacted the Defense Production Act after the Food and Drug ...

Yvonne Hemz was scheduled to have a cancerous tumor removed from her kidney Tuesday. On Sunday, however, Hemze, 52, of Farmington, Minnesota, got a call from the hospital, Abbott Northwestern, telling ...